Cytek Biosciences, Inc. (NASDAQ: CTKB) reported revenue for the quarter came in at $57.5 million versus the consensus estimate of $61.49 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.